Introduction {#s1}
============

Enzymes are the biocatalysts that have specificity, efficiency, and mode of regulation. They are also used for varied industrial processes especially in medical research such as *de novo* drug discovery and its improvement (increase the yield of antibiotics, hormones, etc.), crop improvement, biofuel industry, food industry, etc. Enzymes used in biotechnological process have to be very efficient in their catalytic activity because *in vivo* and *in vitro* conditions are very different. Most of the enzymes are derived from mesophilic organisms; hence they are most active in moderate conditions. Therefore, in order to improve the catalytic performance of the industrial enzymes and withstand harsh conditions, protein engineering plays a major role, and resulting in the reduction of cost and time of processing in the respective industries. Changing cofactor specificity, discovering path of molecular evolution, designing more powerful and efficient enzymes, locating active sites and crucial residues, shifting the substrate specificity toward new substrate, improving binding affinity, changing in pH tolerance and inhibitor tolerance, improving solubility and resistance to extreme conditions, are some of the modifications that can be achieved by *in vitro* enzyme designing. Enzymes can be altered by redesigning the active site that can alter its efficiency (k~cat~/k~m~) and specificity (k~m~). Altering the ligand binding sites, incorporation of new functional groups into the active site, DNA shuffling, site-saturation, and site-directed mutagenesis are some of the approaches that modify the active site of an enzyme. Thermo-stabilizing traits such as high number of hydrogen bonds, introduction of ion pairs for linking of N and C-terminals, addition of proline residues in loops are among many modifications that can be achieved at genetic level through mutagenesis after complete analysis of sequence and structure of homologous mesophilic and thermophilic enzymes. Cryo-stabilizing characteristics such as clustering of glycine residues which provide local flexibility in the region, reduced frequency of proline residues in loops leading to enhanced chain flexibility between secondary structures, a reduction in arginine residues which generally participate in formation of multiple salt bridges and H-bonds, and a lowered number of ion pairs and aromatic interactions, can also be introduced by mutagenesis. These characteristics of thermophilic and cryophilic enzyme can be added in the mesophilic enzyme.

Theodosius Dobzhansky stated that "Nothing in biology makes sense except in the light of evolution" (Dobzhansky, [@B15]). Evolution is the change in heritable phenotypic trait of biological population over successive generations. The amazing similarity in gene sequences and metabolic pathways across the phyla says that modern organisms are derived from common progenitor by series of small changes, i.e., mutations. Homology means two proteins are descended from a common ancestor while sequence homology means amino acids at equivalent positions are similar because they are descended from a common ancestor (Hall and Barlow, [@B25]). The gradual accumulation of mutations over long period of time results in the formation of new species. Natural *in vivo* design of the bioactivity leads to the molecular evolution. Molecular evolution is a fundamental biological process and its understanding would facilitate the engineering of enzymes with new specificities. During the course of evolution, it is possible that inefficient enzymes convert to efficient enzymes or vice-versa (Geddie and Matsumura, [@B18]). The *in vitro* design of the activity can be done using various mutagenesis approaches. Thus, enzyme engineering using *in vitro* approaches may contribute to elucidate structural basis of the functional properties, and the course of the natural molecular evolution. In the present review, we have explained the methods for *In vitro* mutagenesis and their significances in the enzyme substrate replacement, cofactor replacement, and change in enzyme catalysis.

Methods for *in vitro* design or artificial mutation {#s2}
====================================================

Protein engineering technology (Figure [1](#F1){ref-type="fig"}) involves directed evolution, rational designing, semi-rational design, structure-based design using chemical modification, and truncated and fusion methods (Li and Cirino, [@B31]; Kaushik et al., [@B28]). In directed evolution, natural evolution is mimicked in the lab and based on developing molecular diversity by random mutagenesis and *in vitro* recombination followed by performing high-throughput screening for improvements in desired phenotype. Similarly, rational protein design is used for those enzymes whose three-dimensional structures have already been determined and site-directed mutagenesis is used to introduce specific and deliberate mutations on the enzyme sites. Both directed evolution and rational protein design have certain limitations, hence a combined approach known as semi-rational design, takes advantage of already available information of structure and function of the desired protein and designs a smaller but higher quality library. Molecular dynamics and QM studies also compliment such studies as they facilitate the understanding about the impact of every single amino acid on the structure and function of the protein. This computer-guided semi-rational designing of proteins further helps in shaping the needs of a good biocatalyst with a larger substrate range, selectivity, specificity, and stability without harming their catalytic efficiency (Kaushik et al., [@B28]).

![**Summary of enzyme engineering methods and their significances**.](fchem-04-00039-g0001){#F1}

Recent studies have shown that combined computational and *in vitro* evolution approaches can be used for the study of evolution of novel bioactivity in the natural enzymes. *In vitro* study can be achieved by construction of large libraries of protein/enzyme mutants, enzyme with certain substrate binding characteristics are selected, and the sequences of the selected enzyme are determined. The main advantage of this method is that they require minimal knowledge of enzyme substrate interaction under study. This method does not provide much information about the nature of intermolecular contacts, which often hampers an understanding of the obtained results. Computational protein design is parallel approach that is based on our understanding of the biophysical forces that govern enzyme-substrate binding but it require a detailed knowledge of the structure and function of the enzyme substrate under study (Rosenfeld et al., [@B44]).

Other approach using novel scaffolding and compartmentalization techniques are also used to improve performance of enzyme (Li and Cirino, [@B31]). Consensus design is another approach that can be used to artificial designing of enzyme, which is based on the hypothesis that at a given position of enzyme, the respective consensus amino acid contributes more than average to the stability of the enzyme than non-conserved amino acids. Consensus design, like ancestral sequence reconstruction, utilizes evolutionary history; all sequences are aligned, and most frequently observed amino acid is identified at each position in the alignment (Porebski and Buckle, [@B41]). To achieve the molecular evolution of a protein, a consensus library for directed evolution experiments could be made, which would contain information about site-directed mutations of a particular protein. This mimics the natural Darwininan evolution process, which involves repeated cycles of mutation, followed by selection that renders a strong algorithm to create diversity as exhibited by the plethora of life. The process can be performed *in vitro* by introducing random mutations on template strand, followed by screening and selection of desired mutant clones. The whole procedure is repeated until desired mutation is achieved. Selection or screening of a consensus library should reveal correlative or co-varying substitutions that change parallel in order to alter protein function (Flores and Ellington, [@B17]). Redesigning of enzymes does not only require change in the residues that bind to substrates and cofactor but also requires residues that are far from active site but important to maintain catalytic residues in prerequisite orientations. Electrostatic charge distribution throughout a whole enzyme molecule may also facilitate substrate binding by electrostatically guiding the substrate into the active site (Oue et al., [@B39]). The mutagenized gene library is made by various methods such as DNA shuffling, error prone PCR (ePCR) and staggered extension process (StEP). However, the efficiency rate of directed evolution is low and less yield of the final PCR product acts as a drawback for the downstream processing. This can be avoided using ExoSAP-IT PCR Product Cleanup (Affymetrix), that serves as an alternative to beads based PCR (Goh et al., [@B20]).

ePCR incorporates error in the final product during DNA amplification. Errors are introduced by altering the parameters of PCR such as use of high concentrations of magnesium or manganese, DNA polymerase not capable of proofreading, increase in the number of amplification cycles and/or biased concentration of dNTPs. DNA shuffling is one of the most important directed evolution techniques which has increased the catalytic efficiency of various industrial enzymes namely β- 1,3- 1,4-glucanase (Yan et al., [@B55]), glucose dehydogenase (Gruber et al., [@B24]) etc. This technique involves formation of various chimeras by joining different homologous genes via self-priming PCR and ultimately creating a library. More than 80% similarities should be there in homologous parent genes (Brakmann and Schwienhorst, [@B5]). StEP is also a commonly used homology-dependent process for performing *in vitro* DNA recombination. For the purpose of efficient recombination the parental genes must share more than 85% sequence identity (Volkov and Arnold, [@B50]).

Recently, mutagenesis methods have improved tremendously in comparison to earlier laborious primer extension methods that require templates (to be mutated) in single stranded form as well as stringent screening procedures for selection of mutants. Advance methods such as Exsite and GeneTailor uses double stranded template DNA and PCR to mutate the targets followed by easy selection of mutants. Alanine scan is a standard method to analyze the active site mechanism and identify the role of important residues, where the concerned residues are mutated with alanine (Dembowski and Kantrowitz, [@B13]). Hence with the types of technologies available today and with the widely accessible information (web based databases), engineering procedures have become routine and are continuously introducing new enzymes and proteins into market with enhanced traits or novel properties for therapeutic, pharmaceutical and industrial applications. *In vitro* mutagenesis results from the three type of changes i.e., enzyme substrate replacement, cofactor replacement, and change in enzyme catalysis. We have critically analyzes each of these in detail by taking examples of different enzymes. Various enzymes and their mutants formed by site-directed mutagenesis along with the mutation sites are listed in Table [1](#T1){ref-type="table"}.

###### 

**Enzymes and their mutants formed by site directed mutagenesis**.

  **S. no**.   **Source**                              **Wild type enzyme**                    **Substrate specificity/cofactor specificity**                                              **Mutant enzyme**                        **New substrate specificity/cofactor specificity**                                 **Mutations at specific sites**                                                                **References**
  ------------ --------------------------------------- --------------------------------------- ------------------------------------------------------------------------------------------- ---------------------------------------- ---------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------
  1\.          *Trichomonas vaginalis*                 Lactate dehydrogenase                   Lactate etc.                                                                                Malate dehydrogenase                     Malate etc.                                                                        Leu91Arg                                                                                       Wu et al., [@B53]
  2\.          *Citrobacter freundii*                  Tyrosine phenol lyase                   β- elimination of tyrosine                                                                  Dicarboxylic amino acid β-lyase enzyme   Reversible transfer of an amino group from dicarboxylic amino acids to oxo acids   Arg100Thr, Val283Arg                                                                           Mouratou et al., [@B36]
  3\.          *Citrobacter freundii*                  Tyrosine phenol lyase                   β- elimination of tyrosine                                                                  Tyrosine phenol lyase                    Decreased affinity for β- elimination of tyrosine                                  Asn185Ala, Tyr71Phe, Thr124Asp, Phe448His                                                      Chen H. Y. et al., [@B8]; Barbolina et al., [@B2]; Demidkina et al., [@B14]
  4\.          *Lactobacillus pentosus*                NAD-dependent D-lactate dehydrogenase   Pyruvate                                                                                    D-2hydroxyisocaproate dehydrogenase      Larger aliphatic or aromatic 2-ketoacid substrates                                 Tyr52Leu                                                                                       Tokuda et al., [@B46]
  5\.          *E. coli*                               Choline acetyl transferase              Acetyl group acceptor is choline                                                            Carnitine acetyl transferase             Specificity More for carnitine and less for choline                                Val459Thr, Asp460Glu, Asn461Thr Asn514Arg                                                      Reznik et al., [@B42]
  6\.          *E. coli*                               Aspartate amino- transferase            reversible transfer of the amino group of aspartate or glutamate to the cognate oxo acids   L-aspartate-β decarboxylase              β-caboxylase activity                                                              Tyr225Arg, Arg292Lys Arg386Ala                                                                 Graber et al., [@B21]
  7\.          *Bacillus stearothermophilus*           Lactate dehydrogenase                   specific for cofactor NAD~+~                                                                Same                                     Utilized NADP^+^ far better                                                        Phe16Gln, Cys81Ser Asn85Arg                                                                    Flores and Ellington, [@B17]
  8\.          *E. coli*                               β-Glucuronidase                         β- galactosidase activity                                                                   Same                                     Increased in β galactosidase activity                                              Thr509Ala, Ser557Pro, Asn566Ser Lys568Gln                                                      Geddie and Matsumura, [@B18]
  9\.          *E. coli*                               Malate dehydrogenase                    Inter-conversion of malate & oxaloacetate                                                   Same                                     Catalytic activity is decreased & specificity for other substrate increased        Arg153Cys                                                                                      Wright and Viola, [@B52]
  10\.         *E. coli*                               Aspartate amino transferases            Aspartate                                                                                   Same                                     Five-fold increase in activity                                                     Asn34Asp, Ile37Met, Ser139Gly, Asn142Thr, Asn297Ser, Val387Leu                                 Yano et al., [@B54]
  11\.         *E. coli*                               Aspartate amino transferases            Aspartate                                                                                   same                                     Valine                                                                             17 mutations                                                                                   Oue et al., [@B39]
  12\.         *E. coli*                               Streptavidin                            Biotin                                                                                      Same                                     Biotin analogs e.g., Iminobiotin                                                   Asn23Ala Ser27Asp                                                                              Reznik et al., [@B42]
  13\.         *Klebsiella pneumoniae*                 1,2 propanediol oxidoreductase          Coenzyme-NADH                                                                               Same                                     Coenzyme-NADH and NADPH                                                            Asp41Ala, Asp41Gly                                                                             Ma et al., [@B32]
  14\.         *Bacillus lentus*                       Subtilisins                             Proteolytic activity                                                                        Same                                     Increased proteolytic activity                                                     Lys27Arg/ Asn87Ser/ Val104Tyr/ Asn123Ser /Thr274Ala Asn76Asp/ Asn87Ser/ Ser103Ala/ Val104Ile   Graycar et al., [@B22]
  15\.         *Streptomyces* spp.                     Cholestrol oxidase                      Pregnenolone, cholesterol                                                                   Same                                     Increased catalytic activity                                                       Ser379Thr                                                                                      Toyama et al., [@B49]
  16\.         *E. coli*                               Isocitrate dehydrogenase                Coenzyme-NADP                                                                               Same                                     Coenzyme-NAD                                                                       6 mutations                                                                                    Chen R. et al., [@B9]
  17\.         *Peptostreptococcus asaccharolyticus*   Glutamate dehydrogenase                 Coenzyme-NADH                                                                               Same                                     Coenzyme-NADPH                                                                     Glu243Lys/Glu243Asp                                                                            Carrigan and Engel, [@B7]
  18\.         *Candida boidinii*                      Formate dehydrogenase                   Coenzyme-NAD^+^                                                                             Same                                     Coenzyme-NADP^+^                                                                   Asp195Gln/Tyr196His                                                                            Andreadeli et al., [@B1]
  19\.         *E. coli*                               Malate dehydrogenase                    Oxaloacetate                                                                                Phenylactate dehydrogenase               Phenyl pyruvate                                                                    Arg81Cys                                                                                       Wright et al., [@B51]
  20\.         *Streptomyces coelicolor*               Malate dehydrogenase                    NADP                                                                                        same                                     NADPH                                                                              Glu42Gly, Ile43Ser, Pro45Arg, Ala46Ser                                                         Ge et al., [@B19]
  21\.         *Pseudomonas* N176                      Glutaryl-7-ACA acylase                  CephC                                                                                       CephalosporinCacylases (CA)              CephC                                                                              His57Ser His70Ser, Leu154Tyr                                                                   Conti et al., [@B11]
  22\.         *Candida tenuis*                        Xylose reductase                        NADPH                                                                                       Same                                     NADH                                                                               Lys274Arg--Asn276Asp                                                                           Petschacher et al., [@B40]
  23\.         *Thermus thermophilus*                  Lactate dehydrogenase                   NADH                                                                                        Same                                     NADPH                                                                              7 amino acid residues                                                                          Tomita et al., [@B48]
  24\.         *Pichia stipitis*                       Xylose reductase                        NADPH                                                                                       Same                                     NADH                                                                               Lys21Ala/ Asn272Asp                                                                            Zeng et al., [@B56]
  25\.         *Clostridium symbiosum*                 Glutamate dehydrogenase                 NADH                                                                                        Same                                     NADPH                                                                              Asp263Lys, Phe238Ser, Pro262Ser                                                                Griffin and Engel, [@B23]
  26\.         *Thermus flavus*                        Malate dehydrogenase                    NADH                                                                                        Same                                     NADPH                                                                              7 amino acids residues                                                                         Nishiyama et al., [@B37]; Tomita et al., [@B47]
  27\.         *E. coli*                               Lactaldehyde dehydrogenase              NADH                                                                                        Same                                     NADPH                                                                              Phe180Thr                                                                                      Rodríguez-Zavala, [@B43]
  28\.         *Candida magnoliae*                     Carbonyl reductase                      NADPH                                                                                       Same                                     NADH                                                                               8 amino acid residues                                                                          Morikawa et al., [@B34]
  29\.         *Neurospora crassa*                     Nitrate reductase                       NADPH                                                                                       Same                                     NADH                                                                               Ser920Asp Arg932 Asp                                                                           Shiraishi et al., [@B45]
  30\.         *Lactobacillus bulgaricus*              Lactate dehydrogenase                   NADH                                                                                        Same                                     NADPH                                                                              Asp175Ala                                                                                      Bernard et al., [@B4]
  31\.         *Glomerella cingulata*                  Cutinase                                Hydrolysis of esters and triglycerides                                                      Same                                     Catalytically inactive                                                             His204Asn                                                                                      Nyon et al., [@B38]
  32\.         *Pseudomonas aeruginosa* LST- 03        Lipase                                  Ester synthesis and inter-esterification reaction and lipid hydrolysis                      Same                                     Increased organic solvent stability                                                Ser155Leu Gly157Arg, Ser164Lys, Ser194Arg, Asp209Asn                                           Kawata and Ogino, [@B29]
  33\.         *Geobacillus kaustophilus* HTA426       Lactonase                               3-oxo-N-dodecanoyl-L-homoserine lactone                                                     Same                                     72-fold increase in the catalytic efficiency                                       Glu101Asn/ Arg230Ile                                                                           Chow et al., [@B10]
                                                                                               3-oxo-N-dodecanoyl-L-homoserine lactone                                                     Same                                     *N*-butyryl-l-homoserine lactone                                                   Asp266Asn                                                                                      Chow et al., [@B10]
  34\.         alkalophilic Bacillus sp.               Cyclodextrin glucano transferase        produce cyclodextrins from starch                                                           Same                                     higher product yields                                                              His233Tyr                                                                                      Leemhuis et al., [@B30]
  35\.         *E. coli*                               Lactaldehyde reductase                  NADH                                                                                        Same                                     3.6-fold increase in k~cat~                                                        Met185Cys                                                                                      Cahn et al., [@B6]
  36\.         *Saccharomyces cerevisae*               Cinnamyl alcohol dehydrogenase          NAD(P)H                                                                                     Same                                     82-fold increase in activity                                                       Gln110Val                                                                                      Cahn et al., [@B6]
  37\.         *Actinoplanes utahensis*                Cephalosporin acyclase                  Cephalosporin                                                                               Same                                     *Aculeacin A*                                                                      Phe177(β)Gly/Met145(α)Ala and Phe177(β)Gly/Met145(α)Ala/Tyr149(α)Val                           Isogai and Nakayama, [@B27]

Significance of *in vitro* manipulation {#s3}
=======================================

Replacement of natural substrate with a novel substrate
-------------------------------------------------------

The alteration in the substrate specificity is seen mainly in the dehydrogenases. The reason might be the utilization of similar cofactor i.e., NAD by all dehydrogenases. Malate dehydrogenase (MDH) from *Escherichia coli* is highly specific for its keto acid substrate. The replacement of one of the binding arginine residues (81st position) with unnatural aryl and alkyl amino acid analogs, result into enhancement of the specificity of MDH for phenyl pyruvate while diminished for oxaloacetate (physiological substrate; Wright et al., [@B51]). This is performed by site-specific modulation that incorporates systemic structural information at the target site. Similarly, some experiments also revealed that three arginines (80th, 87th, and 153th) of malate dehydrogenase are responsible for selectivity of the substrate. Site-directed mutagenesis at Arg153Cys was done which decreased its specificity for malate and oxaloacetate. This substitution changed the conformation of the active site and thus the specificity for original substrate decreased. Substitutions of functional group like acetamide etc. changed the substrate specificity to pyruvate, alpha-ketoglutarate etc. (Bell et al., [@B3]; Wright and Viola, [@B52]).

Some other studies reported that a single amino acid mutation (Tyr52Leu) was done in NAD-dependent D-lactate dehydrogenase of *Lactobacillus pentosus*, resulted in the increased affinity of enzyme toward larger aliphatic or aromatic 2-ketoacid substrates by four-fold as well as decreased affinity toward pyruvate (which is its actual substrate) by about 30-fold and thus converting the enzyme into D-2-hydroxyisocaproate dehydrogenase (an active enzyme; Tokuda et al., [@B46]).

Likewise, many attempts have been made to redesign the active sites of enzymes such as lactate dehydrogenase (LDH) present in *Trichomonas vaginalis (Tv)*. It resembles malate dehydrogenase (cytosolic) more closely than LDH of other species. The Arg at 91st position of MDH was replaced by Leu in *Tv*LDH. The change Leu91Arg was done by site directed mutagenesis that converted *Tv*LDH to MDH. The reverse change i.e., Arg91Leu does not yield a measurable activity of *Tv*LDH. The result was verified by molecular modeling and *in vitro* functional characterization. This conversion showed that MDH-LDH barrier has been broken in at least one direction. This also highlighted the role of some important residue for selection of catalysis of a substrate. Phylogenetic reconstructions showed that members of the MDH and LDH families form separate monophyletic lineages probably arose from early gene duplication (Wu et al., [@B53]). Similarly, studies suggest that evolution of (*Cryptosporidium parvum*) lactate dehydrogenase from malate dehydrogenase arose by gene duplication. Ancestral sequence reconstruction technique is useful to study these evolutionary paths (Madern et al., [@B33]).

Another enzyme, aspartate aminotransferases are the most extensively studied vitamin B-6 containing enzyme. These are homodimeric enzymes that catalyze amino group transfer between acidic amino acids, aspartate and glutamate, and their corresponding 2-oxo acids. The triple mutation at its substrate-binding site leads to increased rate of L-aspartate β-decarboxylase activity to transaminase activity by 25 million-fold. In order to elucidate both the structural basis of the functional properties and course of the molecular evolution, molecular dynamics, and crystal studies are performed (Graber et al., [@B21]). Similarly, directed molecular evolution was done by mutating 17 amino acids residues of enzyme aspartate aminotransferases in *E. coli*. This had resulted in six-fold increase in activity for non-native substrate i.e., valine. The remodeled enzyme had altered subunit interface, and a shift in the enzyme domain. These results clearly demonstrate the importance of the cumulative effects of residues remote from the active site and present a new line of approach to redesign enzymes (Oue et al., [@B39]).

Molecular dynamics and homology data also identified the critical residues of tyrosine phenol lyase (TPL), an enzyme involved in the β-elimination of tyrosine. Double mutations at R100T and V283R are responsible for switching the substrate specificity of TPL from L-tyrosine to dicarboxylic amino acids in *Citrobacter freundii*. These mutations increased its β-elimination activity toward dicarboxylic acids by four-fold without destroying its catalytic apparatus. Thus, this experiment gave a novel enzyme dicarboxylic amino acid β-lyase, which is not found in nature. From this study, it can be concluded that these enzymes originated from region-specific catalysts, which first specialized for reaction specificity and then for substrate specificity (Mouratou et al., [@B36]).

Site directed mutagenesis has been routinely used to redesign enzymes, but the achievement in this technique relies basically on the availability of 3-D structure protein maps. Others techniques that are based on cross-referencing substrate structure and comparisons with protein alignment data, were also used. Choline acetyltransferases reversibly transfer acetyl group between acetyl-coA and choline. After site-directed mutagenesis the mutant enzyme have more affinity for carnitine rather than choline. Thus, novel enzyme called carnitine/choline acetyltransferase was obtained (Cronin, [@B12]). Likewise, catalytic efficiency of cholesterol oxidase from *Streptomyces* and *Brevibacterium*, was also studied by site directed mutagenesis and found that efficiency was increased in the mutant S379T toward cholesterol and pregnenolone. These findings provide ideas for designing more efficient enzyme which can be clinically useful for cholesterol estimation (Toyama et al., [@B49]).

A well-known industrial biocatalyst Glutaryl acylase (GA), belongs to the N-terminal hydrolase class of hydrolytic enzymes and show wide substrate specificity. CA (cephalosporin C acylase) and GAs are members of the glutaryl acylase family that specifically use CephC as their substrate. GA undergoes a two-step reaction to yield cephalosporin and CA undergoes only one step reaction to yield cephalosporin. CAs isolated from *Pseudomonas* strains has very low activity for biotechnological use. By using protein engineering approach based on combined use of error-prone PCR mutagenesis, molecular modeling, site saturation and site-directed mutagenesis, the glutaryl acylase from *Pseudomonas* N176 has been mutated (A215αY-H57βS-H70βS and H57βS-H70βS-L154βY). These enzyme variants have 100-fold increase in specificity constant for CephC (Conti et al., [@B11]).

In addition to the alteration in the enzymes action, artificial mutation can also alter the proteins for non-catalytic function. Streptavidin and biotin is the model system to study structure and thermodynamic properties of high affinity receptor complexes with its ligand. Biotin binding sites were redesigned in such a way that the major structural motifs of the natural streptavidin-biotin complex are preserved. This was done by changing amino acid residues deep in the biotin-binding pocket to reduce the biotin-binding affinity considerably without disturbing the binding affinities for biotin analogs. Thus, a mutant of streptavidin was made which has greater binding specificity to 2-iminobiotin than to its natural ligand biotin. This approach could also be useful for *in vivo* targeting applications (Reznik et al., [@B42]).

Alteration in coenzyme specificity of enzyme
--------------------------------------------

Cofactor specificity can also be altered by using techniques like site-directed mutagenesis, DNA shuffling etc. The enzyme lactate dehydrogenase has a specific cofactor NAD^+^. Using DNA shuffling method, many mutants were made by substitution at cofactor binding sites. A consensus library was made to study cofactor specificity of *Bacillus stearothermophilus* lactate dehydrogenase. A triple mutant was selected which had decreased specificity for NAD^+^ and increased for NADP^+^. Thus, an enzyme with change in cofactor was made without decrease in its catalytic activity (Flores and Ellington, [@B17]). Similarly, the NAD-dependent D-lactate dehydrogenase from *Lactobacillus bulgaricus* had also been modified to display 40-fold shift of coenzyme specificity from NADH to NADPH (Bernard et al., [@B4]).

Similar experiments were also done in different organisms to change the cofactor specificity. Malate dehydrogenase (MDH) of *Streptomyces coelicolor* (*Sc*MDH) was altered by site-directed mutations in the Rossman fold region to change its cofactor specificity from NADH to NADPH. The coenzyme specificity (*K*~cat~/*K*~m~) of the mutant enzyme was examined and found to be shifted 2231.3-fold toward NADPH (Ge et al., [@B19]). Similarly, in *Thermus thermophilus, Thermus flavus*, and *Thermococcus kodakarensis* replacement of specific amino acids in Rossman fold of NADH dependent lactate dehydrogenase changed its cofactor from NADH to NADPH (Nishiyama et al., [@B37]; Tomita et al., [@B47]; Morimoto et al., [@B35]).

Xylose reductase (NADPH) and xylitol dehydrogenase (NADH) of *Pichia stipiti* are involved in the catabolism of xylose and for ethanol production from it. As the cofactors of both these enzymes are different, redox imbalance occurs. To solve this problem, site directed mutagenesis was done at Lys21 in xylose reductase. Both K21A and K21A/N272D mutants preferred NADH over NADPH. Thus, a complete reversal of coenzyme specificity toward NADH and improved catalytic efficiency were achieved for this enzyme (Zeng et al., [@B56]). In *Candida tenuis*, similar experiments (single mutant K274R, K274M, K274G, S275A, N276D, R280H, and double mutant K274R-N276D) were done to change the cofactor specificity of xylose reductase (Petschacher et al., [@B40]).

Likewise, some residues of glutamate dehydrogenase of *Peptostreptococcus asaccharolyticus* and *Clostridium symbiosum* has been mutated, due to which catalytic efficiency toward NADPH and NADP^+^ was increased by several folds, respectively (Griffin and Engel, [@B23]). Formate dehydrogenase from *Candida boidinii* (CboFDH) is known to catalyse the oxidation of formate anion to carbon dioxide with concomitant reduction of NAD^+^ to NADH. It is highly specific to NADH and virtually fails to catalyze the reaction with NADPH, but substitution at Asp195Gln/Tyr196His position causes shift of cofactor specificity from NADH to NADPH (Andreadeli et al., [@B1]). In isocitrate dehydrogenase from *E. coli*, site-directed mutagenesis was used to introduce five substitutions (Lys344Asp, Tyr345Ile, Val351Ala, Try391Lys, Arg395Ser) in its adenosine binding pocket that shifts the coenzyme specificity from NADP to NAD (Chen R. et al., [@B9]). Studies also suggest that a mutation in phenylacetaldehyde dehydrogenase mutation at F180T in lactaldehyde dehydrogenase increases its specificity to NADP^+^ that also increased enzyme\'s catalytic activity (Rodríguez-Zavala, [@B43]).

Same approach was applied to mutate various other enzymes like nitrate reductase, carbonyl reductase etc. which have been highlighted in Table [1](#T1){ref-type="table"}(Shiraishi et al., [@B45]; Morikawa et al., [@B34]). Microbial production of 1, 3-propanediol has been considered as a competitor to the traditional petrochemical routes. Site directed mutagenesis of 1, 3-propanediol oxidoreductase at Asp48 residue relaxes the cofactor specificity of 1, 3-propanediol toward NADH and NADPH, thereby increasing enzyme efficiency (Ma et al., [@B32]). NADPH-dependent hydroxybenzoate hydroxylase from *Pseudomonas fluorescens* was also subjected to site directed mutagenesis that increases its cofactor specificity for NADH. This was the first report on the coenzyme reversion of a flavoprotein aromatic hydroxylase (Eppink et al., [@B16]).

Change in the catalytic activity of the enzyme
----------------------------------------------

Genetic as well as chemical technologies offer tremendous scope of modifying the basic characteristics of enzymes, e.g., activity, stability, thermal sensitivity etc., to enhance their performance and to make them more suitable for industrial as well as research applications. Aspartate aminotransferases have central role in amino acid metabolism. Out of 13 random mutations, six mutations (Table [1](#T1){ref-type="table"}) contributed maximum to the increased activity. Only six amino acids of the enzyme were directly interacting with substrate and results showed that directed molecular evolution is a powerful technique for enzyme redesigning if an adequate selection system is applied (Yano et al., [@B54]).

Tyrosine phenol lyase of microbial origin from *C. freundii* uses pyridoxal 5′ phosphate as cofactor and catalyzes the β-elimination of L-tyrosine to produce phenol and ammonium pyruvate. The substitution of Asn185Ala results in formation of a mutant, which has decreased affinity for substrate due to destability of quinonoid structure, formed between them (Barbolina et al., [@B2]). Similarly, Tyr71Phe was substituted in Tyrosine phenol- lyase and as a result no detectable activity for β-elimination of L-tyrosine was observed and also decreased activity for other substrate was observed (Chen H. Y. et al., [@B8]). Similarly, Asp124Thr and His448Phe mutations in tryptophan indole-lyase of *Proteus vulgaris*, have little or no β-elimination activity with L-Tyr or 3-fluoro-L-Tyra substrate, but retain significant elimination activity with S-(o-nitro phenyl)-L-cysteine, S-alkyl-L-cysteines, and β-chloroalanine (Demidkina et al., [@B14]). In *E. coli* site-saturation mutagenesis was done and many mutants were made by substituting the active site loop residues. Out of those mutants only some of the substitution mutations increased β--galactosidase activity that is discussed in the Table [1](#T1){ref-type="table"} (Geddie and Matsumura, [@B18]).

Thermodynamics of the *in vitro* design of enzyme {#s4}
=================================================

In continuation of above discussion, it is also important to study the thermodynamic parameters like ΔG, ΔCp, ΔH involved in the evolutionary path of these enzymes. Using thermodynamic divergence of evolutionary path of mesophilic and thermophilic Ribonuclease H1 from their common ancestor has been traced (Hart et al., [@B26]). Analyzing its mutants enormous amount of information about the critical positions in enzyme-substrate selectivity can be collected. This is useful in finding their evolution mechanisms i.e., how these enzymes evolved from their ancestors using ancestral sequence reconstruction etc. (Hart et al., [@B26]). Directed evolution technology to select an enzyme with desired characteristics is one of the earliest and successful methods such as half-life (*t~1/2~*) and activity (*k*~*cat*~) of a cold-adapted Lipase B isolated from *Candida antarctica* were significantly improved from 8 to 211 min and 84 min^−1^ to 1900 min^−1^, respectively.

Conclusions {#s5}
===========

Combined computational and *in vitro* evolution approaches can be used for the study of evolution of novel bioactivity in the natural enzymes as well as redesigning of the function of the enzyme. DNA shuffling, site-saturation mutagenesis, and site-directed mutagenesis are used can be used to redesign the active site of an enzyme, which can alter its efficiency. Artificial alteration of enzyme can be very useful in changing the catalytic efficiency of enzymes, cofactor specificity, and substrate specificity. Many new enzymes that do not occur naturally can also be developed, which are more efficient. Using these approaches, enzymes can be engineered according to the requirement. For example, if there is defect in any enzyme, the existing related enzyme or isozymes could be engineered in such a way so that it can work in place of defected enzyme. Moreover, the evolutionary relation and thermodynamic system drifts over evolutionary time can also be studied.

Future prospects {#s6}
================

Engineered enzymes revolution has been brought about after the discovery of extremophiles, organisms surviving, and thriving in extreme environmental conditions like high temperature, low temperature, high salt, and pH etc. Preliminary studies with extremophile enzymes have provided the researchers vital information about the mechanisms of their adaption of the extreme environments and different catalytic activity. These studies revealed the biochemical and structural features of these enzymes, which facilitated scientists to engineer the mesophilic enzymes to attain thermo- or cryo-stability. Similarly, engineered thermophilic and psychrophilic enzymes attain substrate specificity and activity of mesophilic enzymes and vice versa. For example, thermostable hydrolases (used in starch, food, pharmaceutical, leather, and textile industries), chitinases (used in food, cosmetics, pharmaceuticals, agrochemicals related industries), and phytases (release phosphorus from the phytate are used in animal feed); and cryostable lipases, proteases, phytases, glucanases, and xylanases are used with animal feed; pectinases and xylanases are used in starch hydrolysis at low temperatures; lipases and proteases used in detergent and cleaning industry; lipases are being used in biofuel and energy producing industry etc. Similarly, research activities can also result in the development and production of numerous engineered enzymes with application in industrial processes, therapeutics and household products including food industry, biodiesel, and bioremediation.
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